High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study
- PMID: 193398
- DOI: 10.1016/0002-9343(77)90874-9
High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study
Abstract
Lipid and lipoprotein values, including fasting triglycerides and high density lipoproteins (HDL), low density lipoproteins (LDL) and total cholesterol levels, were obtained on 2,815 men and women aged 49 to 82 years chiefly between 1969 and 1971 at Framingham. In the approximately four years following the characterization of lipids, coronary heart disease developed in 79 of the 1,025 men and 63 of the 1,445 women free of coronary heart diseases. At these older ages the major potent lipid risk factor was HDL cholesterol, which had an inverse association with the incidence of coronary heart disease (p less than 0.001) in either men or women. This lipid was associated with each major manifestation of coronary heart disease. These associations were equally significant even when other lipids and other standard risk factors for coronary heart disease were taken into consideration. A weaker association with the incidence of coronary heart disease (p less than 0.05) was observed for LDL cholesterol. Triglycerides were associated with the incidence of coronary heart disease only in women and then only when the level of other lipids was not taken into account. At these ages total cholesterol was not associated with the risk of coronary heart disease.
Similar articles
-
A population at risk. Prevalence of high cholesterol levels in hypertensive patients in the Framingham Study.Am J Med. 1986 Feb 14;80(2A):23-32. doi: 10.1016/0002-9343(86)90157-9. Am J Med. 1986. PMID: 3946458
-
High-density lipoprotein cholesterol concentration and other serum lipids in an isolated island community free of coronary heart disease.Int J Epidemiol. 1979 Sep;8(3):219-25. doi: 10.1093/ije/8.3.219. Int J Epidemiol. 1979. PMID: 231577
-
Diabetes, blood lipids, and the role of obesity in coronary heart disease risk for women. The Framingham study.Ann Intern Med. 1977 Oct;87(4):393-7. doi: 10.7326/0003-4819-87-4-393. Ann Intern Med. 1977. PMID: 199096
-
Lipid measurements for coronary risk assessment: a review.Am J Med Technol. 1981 Jul;47(7):539-43. Am J Med Technol. 1981. PMID: 7025628 Review.
-
Current status and future directions in lipid management: emphasizing low-density lipoproteins, high-density lipoproteins, and triglycerides as targets for therapy.Vasc Health Risk Manag. 2010 Mar 3;6:73-85. doi: 10.2147/vhrm.s8725. Vasc Health Risk Manag. 2010. PMID: 20234782 Free PMC article. Review.
Cited by
-
Effect of repeated apoA-IMilano/POPC infusion on lipids, (apo)lipoproteins, and serum cholesterol efflux capacity in cynomolgus monkeys.J Lipid Res. 2013 Sep;54(9):2341-53. doi: 10.1194/jlr.M033779. Epub 2013 Jul 4. J Lipid Res. 2013. PMID: 23828780 Free PMC article.
-
Segregation of LIPG, CETP, and GALNT2 mutations in Caucasian families with extremely high HDL cholesterol.PLoS One. 2012;7(8):e37437. doi: 10.1371/journal.pone.0037437. Epub 2012 Aug 27. PLoS One. 2012. PMID: 22952570 Free PMC article.
-
Effect of nicardipine on fasting plasma lipids and apolipoproteins in male new zealand white rabbits.Malays J Med Sci. 1999 Jul;6(2):5-11. Malays J Med Sci. 1999. PMID: 22589682 Free PMC article.
-
Lipoprotein heterogeneity in persons with Spinal Cord Injury: a model of prolonged sitting and restricted physical activity.Lipids Health Dis. 2015 Jul 28;14:81. doi: 10.1186/s12944-015-0084-4. Lipids Health Dis. 2015. PMID: 26215870 Free PMC article.
-
Homocysteine diminishes apolipoprotein A-I function and expression in patients with hypothyroidism: a cross-sectional study.Lipids Health Dis. 2016 Jul 26;15:123. doi: 10.1186/s12944-016-0293-5. Lipids Health Dis. 2016. PMID: 27457726 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical